T Cell Biomarkers in Autoimmunity for Target Discovery & Treatment Monitoring

Time: 10:00 am
day: Day One


  • Use T-cell repertoire to determine HLA type for high-risk alleles
  • Monitor-T cell response to immune modifying therapies as a biomarker of activity
  • Map T-cell clones to self-antigens to identify disease targets and track antigenspecific response to therapy